The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review
Meta-analysis / review
Abstract
This systematic review of six randomised double-blind placebo-controlled trials found that the majority favour feverfew (Tanacetum parthenium) over placebo for migraine prevention, with only mild transient adverse effects, concluding feverfew is likely effective and safe for migraine prophylaxis.
Referenced for these plants
How to cite
Ernst, E. and Pittler, M.H (2000) 'The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review', Public Health Nutrition, 3(4A), pp. 509-514. doi:10.1017/s1368980000000598
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.